Uptake of targeted therapy in a large cohort of patients with advanced prostate cancer and germline pathogenic variants.
Authors
- Hiba M. Khan (ORCID: https://orcid.org/0000-0002-4877-8028)
- Emily M. Russell (ORCID: https://orcid.org/0000-0001-9151-0310)
- Sarah M. Nielsen (ORCID: https://orcid.org/0000-0002-5916-6393)
- Heather H. Cheng (ORCID: https://orcid.org/0000-0002-1365-0702)
Institutions
- University of Washington (US)
- LabCorp (United States) (US)
- Fred Hutch Cancer Center (US)
- Invitae (United States) (US)